Michael Ierardi, PA
Surgical · Peabody, MANPI 1538147012
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 27 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Zimmer Biomet at 32.6% of the total. Reporting peaked in 2024 at $299 and has fallen 62.1% since, to $113 in 2025.
Across 27 payments — averaging $34.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$305
- Abbott$173
- Ferring Pharmaceuticals Inc.$86
- Smith+Nephew$79
- Orthofix Medical, Inc.$73
- Bioventus LLC$68
- plus $152 from 5 others
What the payments were for
- Food & beverage$936100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 5 | $305 |
| Abbott | 2 | $173 |
| Ferring Pharmaceuticals Inc. | 5 | $86 |
| Smith+Nephew | 4 | $79 |
| Orthofix Medical, Inc. | 2 | $73 |
| Bioventus LLC | 3 | $68 |
| Saluda Medical Americas, Inc. | 1 | $50 |
| Pacira Pharmaceuticals Incorporated | 2 | $41 |
| Pacira Therapeutics, Inc. | 1 | $30 |
| Acumed LLC | 1 | $17 |
| Johnson & Johnson | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$936 in reported general payments places this provider in the 80th percentile of 312 surgical providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 24 | $820 |
| Oxycodone Hcl | 70 | $408 |
| Diclofenac Sodium | 15 | $173 |
| Meloxicam | 48 | $130 |
| Prednisone | 18 | $62 |
| Ondansetron Hcl | 15 | $53 |
| Tramadol Hcl | 29 | $45 |
| Amoxicillin | 13 | $9 |
Paid to pharmacies, not to this prescriber.
Other surgical in Peabody
- Jarett LandmanPeabody$5K
- Christopher StantonPeabody$965
- Benjamin SmithPeabody$926
- Gregory DeconciliisWaltham$27K
- Lampros MinosWaltham$18K
- Nicolas DesjardinsSomerville$10K
- Robert KenneyChestnut Hill$8K
- Michael LlewellynBoston$8K
- Anargyros SkaliotisNorth Dartmouth$7K
- Caily IrwinCambridge$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.